Phio Pharmaceuticals Appoints New Chief Medical Officer
Ticker: PHIO · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, personnel
TL;DR
Phio Pharma names Dr. Chang as CMO, boosting clinical leadership.
AI Summary
Phio Pharmaceuticals Corp. announced on February 19, 2025, the appointment of Dr. Michael H. Chang as Chief Medical Officer. Dr. Chang brings extensive experience in clinical development and medical affairs, most recently serving as Chief Medical Officer at Verastem Oncology. This appointment is part of Phio's ongoing efforts to advance its therapeutic candidates.
Why It Matters
The appointment of a new Chief Medical Officer signals a strategic move by Phio Pharmaceuticals to bolster its leadership in clinical development, potentially accelerating the progress of its drug candidates.
Risk Assessment
Risk Level: medium — The appointment of a new executive can introduce changes in strategy or execution, and the success of the company's drug development pipeline remains a key risk factor.
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Registrant
- Dr. Michael H. Chang (person) — Appointed Chief Medical Officer
- Verastem Oncology (company) — Dr. Chang's previous employer
- February 19, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer of Phio Pharmaceuticals Corp.?
Dr. Michael H. Chang has been appointed as the new Chief Medical Officer.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on February 19, 2025.
What was Dr. Michael H. Chang's most recent role before joining Phio Pharmaceuticals?
Dr. Chang's most recent role was Chief Medical Officer at Verastem Oncology.
What is the primary business of Phio Pharmaceuticals Corp.?
Phio Pharmaceuticals Corp. is in the business of Pharmaceutical Preparations.
What is the state of incorporation for Phio Pharmaceuticals Corp.?
Phio Pharmaceuticals Corp. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 by Dr. Michael H. Chang regarding Phio Pharmaceuticals Corp. (PHIO).